Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7303 p732
12 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Guide on porcine-derived drugs launched

New guide will inform patients about medicines of animal origin

A guide for health care professionals about drugs of porcine origin has been launched by the Medicines Partnership.

The guide aims to promote patient choice by allowing patients to make informed decisions about treatment options. As well as listing drugs of porcine origin and alternatives to them, the guide provides information about which patients are most likely to be concerned about using porcine-derived products and how to involve them in decisions.

Use of porcine-derived medicines is most likely to be an issue for people of two faiths: Judaism and Islam. Both strictly forbid pork in the diet. However, people with other beliefs might also choose not to eat pork, particularly those who follow vegetarian diets (which includes believers in Buddhism, Hinduism and Sikhism).

The Medicines Partnership says that leaders of the Muslim and Jewish communities have agreed that the guide represents a major step forward in informing patients about their options in relation to medicines of animal origin. The guide points out that patients are more likely to follow treatment if their views are taken into account and that expanding patient choice is a key objective of the NHS.

A version of the booklet for patients is now being developed.

Copies of the guide for health care professionals can be obtained from the Medicines Partnership (tel 020 7572 2474, website www.medicines-partnership.org).

Back to Top


©The Pharmaceutical Journal